Samaneh Samami

The Epigenetic Drug 5-Azacytidine Interferes with Cholesterol and Lipid Metabolism*

D. Vance, G. Hatch, G. Mayer, 2014, The Journal of Biological Chemistry.

ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)

S. Lévesque, J. Tardif, M. Dubé, 2018, Circulation.

PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver

C. Des Rosiers, G. Mayer, H. Ong, 2015, Arteriosclerosis, thrombosis, and vascular biology.